Parents and patients need to be educated about Risperdal side effects and when or if the medication should be stopped. Tardive dyskinesia, hyperprolactinemia, hyperglycemia, and Neuroleptic Malignant Syndrome are potentially fatal effects that have been associated while taking Risperdal (Drugs.com, 2008).   
 
 

References

Autism Research Institute. (2009). What is autism? Retrieved Feb. 11, 2009, from http://www.autism.com/autism/index.htm.

Drugs.com. (2008). Consumer information risperdal. Retrieved Feb. 12, 2009, from http://www.drugs.com/risperdal.html

Janssen. (2007). Risperdal-autism. Retrieved Feb.12, 2009, from       http://www.janssen.com/janssen/products_risperdal-autism.html

Janssen. (n.d.). Risperdal. Highlights of prescribing information. Retrieved Feb.12,2009, from http://www.risperdalautism.com/risperdalautism/shared/pi/risperdal.pdf#zoom=100

Rxlist.com. (2009). Risperdal indications & dosage. Retrieved Feb. 28, 2009, from http://www.rxlist.com/risperdal-drug.htm

      United States Food and Drug Administration. (October 2006). FDA approves the first drug to treat irritability associated with autism, risperdal. Retrieved Feb.12, 2009, from    http://www.fda.gov/bbs/topics/news/2006/new01485.html

United States Food and Drug Administration. (November 2008). One year post-exclusivity adverse event review: risperidone. Retrieved Feb.12, 2009, from http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4399s1-04%20(Risperidone).pdf

 

Back to Top

Bookmark this page

Digg Facebook Google Bookmarks Stumbleupon Livejournal Twitter